FIELD: biotechnology. SUBSTANCE: invention relates to medicinal preparations containing substances of unknown structure produced by bacteria and development of immunostimulating preparation based on lactic acid bacteria. Strains Streptococcus faecium 3185-M B-349 and Streptococcus faecium M VKPM B-3490 were taken as strains of lactic acid bacteria and produced as dry concentrate of monocultures and mixed at ratio = (0.6-1.4):(0.6-1.4) by viable cells amount. Preparation shows high biological activity involving immunostimulating activity, inhibits pathogenic and opportunistic microflora and has no serum immunoglobulins. Preparation enhances immune status, resistance, stress resistance and adaptation capability of human and animal organism. EFFECT: enhanced effectiveness of preparation.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR METABOLIC PROCESSES INTENSIFYING IN LIVER | 2003 |
|
RU2342152C2 |
| STRAIN OF BACTERIUM STREPTOCOCCUS FAECIUM USED FOR CONTROL OF DYSBACTERIOSIS IN AGRICULTURE ANIMALS | 1993 |
|
RU2152433C1 |
| STARTER FOR PICKLING FRUIT | 0 |
|
SU1805860A3 |
| APPLICATION OF Enterococcus faecium M AND Enterococcus faecium M-3185 STRAINS FOR GLYCOLYSIS SPEED INCREASE AND METHOD OF GLYCOLYSIS SPEED INCREASE | 2007 |
|
RU2426782C2 |
| METHOD AND AGENT FOR TREATING VIRUS HEPATITIS BASED ON Enterococcus faecium M (VKPM B-3490) AND Enterococcus faecium M-3185 (VKPM B-3491) STRAINS | 2007 |
|
RU2445107C2 |
| VETERINARY PROBIOTIC PREPARATION | 1999 |
|
RU2166323C2 |
| BIOPREPARATION- PROBIOTIC, METHOD FOR ITS PREPARING AND STRAIN STREPTOCOCCUS FAECIUM TE-17 FOR PREPARING BIOPREPARATION-PROBIOTIC FOR ANIMALS AND POULTRY | 2001 |
|
RU2217493C2 |
| CONSORTIUM OF LACTOBACILLUS PARABUCHNERI 6, LACTOBACILLUS PLANTARUM 20, LACTOBACILLUS ACIDOPHILUS 22, ENTEROCOCCUS FAECIUM 4/6, BRETTANOMYCES BRUXELLENSIS 75 STRAINS USED FOR PREPARING A PROBIOTIC PREPARATION FOR ANIMALS, BIRDS, FISH, REPTILES, AMPHIBIANS, INVERTEBRATES | 2022 |
|
RU2797585C1 |
| METHOD FOR OBTAINING A FUNCTIONAL FOOD FOR AFTERCARE OF ONCOLOGIC PATIENTS | 2016 |
|
RU2659240C2 |
| METHOD OF KVASS PRODUCING | 1993 |
|
RU2061392C1 |
